L'Oreal says weight-loss drugs are affecting beauty and skin care sales
· 50-word read
In 50 words
L'Oreal said weight-loss drugs known as GLP-1s are affecting beauty and skin care spending, as it develops products for side effects such as skin sagging. The company reported sales up 7.7% in the three months to September, ahead of analyst expectations, according to its head, Nicolas Hieronimus.
